母细胞性浆细胞样树突状细胞肿瘤:儿童、青少年和年轻成人(AYA)的综合综述及新型疗法更新
母细胞性浆细胞样树突状细胞肿瘤(BPDCN)可累及骨髓、外周血、皮肤、淋巴结及中枢神经系统,儿童发病率极低。儿童BPDCN被认为临床侵袭性较低但初诊时播散更常见,多数儿童可经高危急性淋巴细胞白血病样方案治愈,高危或复发难治者推荐造血干细胞移植。本文综述近20年儿童病例及成人和儿童在研新型靶向疗法。
要点
- 儿童BPDCN发病率极低,被认为临床侵袭性低于成人但初诊时播散更常见。
- 多数儿童可经高危急性淋巴细胞白血病样方案治愈,高危或复发难治者推荐造血干细胞移植。
- CD123靶向药物(嵌合抗原受体T细胞、单克隆/双特异性抗体)等新型药物正在进入研究和实践。
核心结论
- 儿童BPDCN被认为临床侵袭性较低但初诊时播散更常见,多数儿童可经高危急性淋巴细胞白血病样方案治愈。
- 高危儿童或复发难治儿童推荐造血干细胞移植,高危定义仍在演变,复发难治者结局仍差。
- CD123靶向药物等新型药物正在进入研究和实践。
研究设计与样本
- 综述近20年报告的儿童BPDCN病例,并综述成人和儿童在研新型靶向疗法。
主要发现
- BPDCN可累及骨髓、外周血、皮肤、淋巴结和中枢神经系统,虽更常见于老年人但各年龄组均有报告,包括婴儿和儿童。
- 儿童BPDCN发病率极低,疾病认识有限,被认为临床侵袭性较低但初诊时播散较成人更常见。
- 与成人若符合移植条件几乎均在首次完全缓解后接受造血干细胞移植不同,多数儿童可经高危急性淋巴细胞白血病样方案治愈。
- 儿童高危疾病定义仍在演变,复发和难治情况下结局仍差。
关键数值与推荐
- 高危儿童或复发难治儿童推荐造血干细胞移植。
临床怎么用
- 多数儿童BPDCN可经高危急性淋巴细胞白血病样方案治愈,高危或复发难治儿童推荐造血干细胞移植。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy that can involve the bone marrow, peripheral blood, skin, lymph nodes, and the central nervous system. Though more common in older adults, BPDCN has been reported across all age groups, including infants and children. The incidence of pediatric BPDCN is extremely low and little is known about the disease. Pediatric BPDCN is believed to be clinically less aggressive but often with more dissemination at presentation than adult cases. Unlike adults who almost always proceed to a hematopoietic stem cell transplantation in first complete remission if transplant-eligible, the majority of children can be cured with a high-risk acute lymphoblastic leukemia-like regimen. Hematopoietic stem cell transplantation is recommended for children with high-risk disease, the definition of which continues to evolve, or those in relapse and refractory settings where outcomes continue to be dismal. Novel agents used in other hematologic malignancies and CD123 targeted agents, including chimeric antigen receptor T-cells and monoclonal/bispecific antibodies, are being brought into research and practice. Our goal is to provide a comprehensive review of presentation, diagnosis, and treatment by review of pediatric cases reported for the last 20 years, and a review of novel targeted therapies and therapies under investigation for adult and pediatric patients.
引用
- Cuglievan B, Connors J, He J, et al. Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies. Leukemia. 2023. PMID: 37452102. doi:10.1038/s41375-023-01968-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。